Zhang Hui, Zhang Tingguo, You Zongbing, Zhang Youzhong
Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Department of Obstetrics and Gynecology, Affiliated Hospital of Taishan Medical College, Taian, Shandong, China.
PLoS One. 2015 Dec 1;10(12):e0142868. doi: 10.1371/journal.pone.0142868. eCollection 2015.
To determine the clinicopathologic and immunohistochemical predictors of the persistence/recurrence of cervical intraepithelial neoplasia (CIN) after cervical conization.
Medical records of 502 patients who received cervical conization treatment of CIN between 2005 and 2012 were reviewed. The clinicopathologic parameters were analyzed using Cox hazard regression. Fifty patients with CIN persistence/recurrence were matched to 50 cases without CIN persistence/recurrence. These 100 cervical specimens were assessed for expression of insulin-like growth factor II messenger RNA (mRNA)-binding protein 3 (IMP3), targeting protein for xenopus kinesin-like protein 2 (TPX2), and programmed cell death-1 ligand-1 (PD-L1) using immunohistochemical staining.
Multivariate analysis found that the independent predictors of CIN persistence/recurrence were positive surgical margin (hazard ratio 5.777, 95% confidence interval 2.334-14.301, p < 0.001) and human papilloma virus persistence for 6 months (hazard ratio 20.685, 95% confidence interval 7.350-57.657, p < 0.001). Co-expression of TPX2 and PD-L1 was significantly higher in CIN persistence/recurrence group than the group without CIN persistence/recurrence (p = 0.013). The depth of glandular involvement (GI) was less than 3mm in about 86.8% (59/68) CIN2-3 lesions, However, No statistically significant associations between GI and persistence/recurrence were observed (P = 0.58).
Positive surgical margin, HPV persistence, and expression of both TPX2 and PD-L1 are associated with persistence/recurrence of cervical intraepithelial neoplasia after cervical conization.
确定宫颈锥切术后宫颈上皮内瘤变(CIN)持续存在/复发的临床病理及免疫组化预测因素。
回顾了2005年至2012年间接受CIN宫颈锥切治疗的502例患者的病历。使用Cox风险回归分析临床病理参数。将50例CIN持续存在/复发的患者与50例无CIN持续存在/复发的患者进行匹配。使用免疫组化染色评估这100份宫颈标本中胰岛素样生长因子II信使核糖核酸(mRNA)结合蛋白3(IMP3)、非洲爪蟾驱动蛋白样蛋白2靶向蛋白(TPX2)和程序性细胞死亡1配体1(PD-L1)的表达。
多因素分析发现,CIN持续存在/复发的独立预测因素为手术切缘阳性(风险比5.777,95%置信区间2.334 - 14.301,p < 0.001)和人乳头瘤病毒持续存在6个月(风险比20.685,95%置信区间7.350 - 57.657,p < 0.001)。CIN持续存在/复发组中TPX2和PD-L1的共表达显著高于无CIN持续存在/复发组(p = 0.013)。在约86.8%(59/68)的CIN2 - 3病变中腺管受累(GI)深度小于3mm,然而,未观察到GI与持续存在/复发之间有统计学意义的关联(P = 0.58)。
手术切缘阳性、HPV持续存在以及TPX2和PD-L1的表达均与宫颈锥切术后宫颈上皮内瘤变的持续存在/复发相关。